Pharmafrontiers is a biotechnology company developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, cardiovascular disease, and diabetes. They needed a logo and identity to convey their leadership position in developing autologous personalized cell therapies for the treatment of various diseases. Pharmafrontier's focus on its proprietary stem cell and T-cell technologies for the autologous use of peripheral blood derived adult stem cells in regenerative medicine lead to a series of icon studies exploring and breaking down the core message of the company down to its most basic visual components. The quad-cell icon was the end result of the process.